Brief: Balaxi Pharmaceuticals Approved Preferential Issue Of Warrants
05/09/2022 10:47
Sept 5 (Reuters) - Balaxi Pharmaceuticals Ltd BALX.NS :
* APPROVED PREFERENTIAL ISSUE OF 1,075,500 WARRANTS
* APPROVED PREFERENTIAL ISSUE OF 24500 SHARES AT ISSUE PRICE
OF
451 RUPEES
* WARRANTS CONVERTIBLE INTO SHARES AT ISSUE PRICE OF 451
RUPEES
Further company coverage: BALX.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Balaxi Pharmaceuticals
See all newsBrief: Balaxi Pharmaceuticals Received WHO-GMP Certification For Jadcherla Facility
India's Balaxi Pharma up after Africa, Latam expansion
Brief: Balaxi Pharmaceuticals Expands Global Reach With Hospital Partnerships In Angola
Brief: Balaxi Pharmaceuticals To Set Up Pharmaceutical Formulation Plant In A Phased Manner
Brief: Balaxi Pharmaceuticals Approves Set Up Of First Pharmaceutical Formulation Plant At Jadcherla, Hyderabad